Paul A. Koehn Net Worth

The estimated Net Worth of Paul A. Koehn is at least $4.1 Million dollars as of 31 May 2017. Paul Koehn owns over 20,000 units of Cardiovascular Systems stock worth over $2,079,780 and over the last 16 years Paul sold CSII stock worth over $2,018,707.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Paul Koehn CSII stock SEC Form 4 insiders trading

Paul has made over 39 trades of the Cardiovascular Systems stock since 2011, according to the Form 4 filled with the SEC. Most recently Paul exercised 20,000 units of CSII stock worth $188,000 on 31 May 2017.

The largest trade Paul's ever made was exercising 30,910 units of Cardiovascular Systems stock on 10 October 2016 worth over $272,935. On average, Paul trades about 3,579 units every 43 days since 2009. As of 31 May 2017 Paul still owns at least 103,989 units of Cardiovascular Systems stock.

You can see the complete history of Paul Koehn stock trades at the bottom of the page.

What's Paul Koehn's mailing address?

Paul's mailing address filed with the SEC is 1225 OLD HIGHWAY 8 NW, , ST. PAUL, MN, 55112.

Insiders trading at Cardiovascular Systems

Over the last 16 years, insiders at Cardiovascular Systems have traded over $72,999,461 worth of Cardiovascular Systems stock and bought 949,532 units worth $8,687,068 . The most active insiders traders include Capital Management Lp Camber, Augustine Lawlor, and Capital Ltdmaverick Capital.... On average, Cardiovascular Systems executives and independent directors trade stock every 14 days with the average trade being worth of $338,920. The most recent stock trade was executed by Martha Goldberg Aronson on 15 August 2022, trading 2,411 units of CSII stock currently worth $48,220.

What does Cardiovascular Systems do?

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company's orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.

Complete history of Paul Koehn stock trades at Cardiovascular Systems

Cardiovascular Systems executives and stock owners

Cardiovascular Systems executives and other stock owners filed with the SEC include:

• Scott Ward,
  Chairman of the Board, President, Chief Executive Officer
• Rhonda Robb,
  Chief Operating Officer
• Scott Raymond Ward B.Sc., M.S., MS,
  Chairman, Pres & CEO
• Scott Raymond Ward M.S., MS, B.Sc.,
  Chairman, Pres & CEO
• Jeffrey Points,
  Chief Financial Officer
• Alexander Rosenstein,
  General Counsel and Corporate Secretary
• Ryan Egeland,
  Chief Medical Officer
• Rhonda J. Robb,
  Chief Operating Officer
• Sandra Sedo,
  Chief Compliance Officer
• Jeffrey S. Points,
  Chief Financial Officer
• Alexander Rosenstein,
  Gen. Counsel & Corp. Sec.
• Dr. Ryan D. Egeland M.D., Ph.D.,
  Chief Medical Officer
• Edward Brown,
  Independent Director
• Augustine Lawlor,
  Independent Director
• Martha Aronson,
  Independent Director
• Erik Paulsen,
  Independent Director
• William Cohn,
  Independent Director
• Stephen Stenbeck,
  Independent Director
• Stephen Rempe,
  Chief Human Resource Officer
• Kelvin Womack,
  Independent Director
• David Whitescarver,
  Vice President - Corporate Development and Intellectual Property
• John Hastings,
  Vice President - Manufacturing and Operations
• Stephen J. Rempe,
  Chief HR Officer
• David S. Whitescarver,
  VP of Corp. Devel. & Intellectual Property
• Sandra M. Sedo,
  Chief Compliance Officer
• John M. Hastings,
  Exec. VP of Operations & Technology
• John E. Nielsen,
  VP of Investor Relations & Corp. Communications
• Brent G Blackey,
  Director
• Leslie Trigg,
  Director
• Capital Management Lp Camber,
  10% owner
• Scott A Bartos,
  Director
• Laurence L Betterley,
  Chief Financial Officer
• Kevin J. Kenny,
  Chief Operating Officer
• Laura Gillund,
  Chief Talent Officer
• Sachin H. Jain,
  Director
• Capital Ltdmaverick Capital...,
  
• Gary M Petrucci,
  Director
• Paul A. Koehn,
  SVP Quality & Operations
• James E Flaherty,
  Chief Administrative Officer
• Glen D Nelson,
  Director
• Robert J Thatcher,
  Executive VP
• David Martin,
  President and CEO
• Geoffrey O Hartzler,
  Director
• Brian Doughty,
  VP of Marketing
• Paul A Tyska,
  VP of Business Dev
• Roger J Howe,
  Director
• Group I, Llc Donoghue Danie...,
  
• John H Friedman,
  Director
• Scott William Kraus,
  VP Sales
• Advisors, Inc Bonderman Dav...,
  
• Geoffrey M Duyk,